glp 1 medications covered by insurance Medicare GLP-1 Drug Coverage Major insurance changes are coming
Description
Stanford reports research funding from the National Institutes of Health
Industry opponents argue this would create labeling divergence between brands and generics, confusing physicians and patients
Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage
The abdomen also offers a generous surface area for rotation, making it easy to find a fresh spot each week
Thyroid Cancer The FDA labels for Ozempic, Wegovy, Mounjaro, and Zepbound all include a black box warning about the risk of thyroid C-cell tumors
Korner, M., Waser, B
